1. Home
  2. MDIA vs ZLAB Comparison

MDIA vs ZLAB Comparison

Compare MDIA & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDIA
  • ZLAB
  • Stock Information
  • Founded
  • MDIA 2019
  • ZLAB 2013
  • Country
  • MDIA United States
  • ZLAB Cayman Islands
  • Employees
  • MDIA N/A
  • ZLAB N/A
  • Industry
  • MDIA Broadcasting
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDIA Consumer Discretionary
  • ZLAB Health Care
  • Exchange
  • MDIA Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • MDIA N/A
  • ZLAB 3.5B
  • IPO Year
  • MDIA N/A
  • ZLAB 2017
  • Fundamental
  • Price
  • MDIA $1.15
  • ZLAB $32.53
  • Analyst Decision
  • MDIA
  • ZLAB Buy
  • Analyst Count
  • MDIA 0
  • ZLAB 4
  • Target Price
  • MDIA N/A
  • ZLAB $47.37
  • AVG Volume (30 Days)
  • MDIA 32.0K
  • ZLAB 1.6M
  • Earning Date
  • MDIA 04-15-2025
  • ZLAB 05-08-2025
  • Dividend Yield
  • MDIA N/A
  • ZLAB N/A
  • EPS Growth
  • MDIA N/A
  • ZLAB N/A
  • EPS
  • MDIA N/A
  • ZLAB N/A
  • Revenue
  • MDIA $95,571,000.00
  • ZLAB $398,988,000.00
  • Revenue This Year
  • MDIA N/A
  • ZLAB $45.57
  • Revenue Next Year
  • MDIA N/A
  • ZLAB $47.91
  • P/E Ratio
  • MDIA N/A
  • ZLAB N/A
  • Revenue Growth
  • MDIA 195.05
  • ZLAB 49.59
  • 52 Week Low
  • MDIA $0.92
  • ZLAB $15.00
  • 52 Week High
  • MDIA $5.73
  • ZLAB $39.77
  • Technical
  • Relative Strength Index (RSI)
  • MDIA 50.52
  • ZLAB 51.76
  • Support Level
  • MDIA $1.08
  • ZLAB $28.34
  • Resistance Level
  • MDIA $1.22
  • ZLAB $33.45
  • Average True Range (ATR)
  • MDIA 0.09
  • ZLAB 2.34
  • MACD
  • MDIA 0.00
  • ZLAB -0.02
  • Stochastic Oscillator
  • MDIA 55.56
  • ZLAB 61.00

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: